Nixon Peabody LLP
Compositions comprising glucosylated hydroxymethylated bases
The present invention provides for novel methods for regulating and detecting the cytosine methylation status of DNA. The invention is based upon identification of a novel and surprising catalytic activity for the family of TET proteins, namely TET1, TET2, TET3, and CXXC4. The novel activity is related to the enzymes being capable of converting the cytosine nucleotide 5-methylcytosine into 5-hydroxymethylcytosine by hydroxylation.
THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES CHILDREN'S MEDICAL CENTER CORPORATION
C C C G C C G C C C C C G C C C
C12Q C12N C12Q G01N C12Q C12N G01N C12Q C12N C12N C12Q C12Q G01N C12Q C12Q C12N
inventional additional inventional additional additional additional inventional additional inventional inventional additional inventional inventional additional inventional additional
Suneet Kian Peng Anjana Aravind Mamta
Agarwal Koh Rao Iyer Tahiliani